Abstract circRNAs, as a kind of non-coding RNA, are characterized by rich content, high stability, and tissue specificity, and have become a research focus in recent years. A large number of studies have found that circRNA and miRNA have the strongest binding capacity among competing endogenous RNAs, playing a role as a miRNA molecular sponge in cellular gene expression and playing an important role in many diseases. At present, studies have shown that circRNAs are closely related to cerebrovascular diseases and play a crucial role in vascular endothelial cells, metabolism of low-density lipoprotein, smooth muscle cells, inflammatory oxidative stress, ischemia-reperfusion, and other regulatory mechanisms. In order to systematically understand circRNA and its function, in order to understand the research progress of circRNA in regulating the molecular mechanism of cerebrovascular diseases, and in order to find potential markers and drug molecules in the field of cerebrovascular disease occurrence, development, diagnosis, and treatment targets, we reviewed the research progress of circRNA in the development of cerebrovascular disease.
Introduction
As a kind of non-coding RNA, circRNAs have become a research hotspot in recent years due to its rich content, high stability, and tissue specificity. It acts as competitive endogenous RNA, playing the role of miRNA molecular sponge in cellular gene expression, and most of them can play a regulatory role in transcription or post-transcriptional level, and a few circRNAs can be encoded as polypeptides and have regulatory functions. The ability of circRNA to bind to miRNA is the strongest in competitive endogenous RNA and is therefore referred to as the Bsuper sponge.^Important functions of circRNA have been found in studies of various diseases, including tumors, heart disease, diabetes, arthritis, and Alzheimer's disease. Current studies have shown that circRNA plays a crucial role in the regulation of vascular endothelial cells, smooth muscle cells, inflammatory oxidative stress, ischemia-reperfusion, and the metabolism of low-density lipoprotein, which is helpful to reveal the molecular mechanism of circRNA regulating the occurrence and development of cerebrovascular diseases. We believe that circRNA is expected to become a potential marker and drug molecular target in the field of cerebrovascular diseases due to its unique advantages, providing new ideas for the occurrence, development, diagnosis, treatment, and rehabilitation of cerebrovascular diseases. Therefore, in order to study the development of circRNA in the mechanism of cerebrovascular disease, our review is as follows:
The Re-recognition of circRNA
In 1979, Hsu first observed the presence of RNA in the cytoplasm of eukaryotic cells in a circular form using an electron microscope [1] . However, at the time, the scientific community only considered circRNA to be a class of low-abundance RNA molecules formed by incorrect splicing of exon transcriptional processes, so few researches have been done on them. With the rapid development of technologies such as RNA sequencing and bioinformatics, large-scale studies of transcriptome data have revealed that many RNAs that were previously considered to be Bjunk^have been proved to have important biological This article is part of the Topical Collection on Medicine * Yi Bao karlbaoyi@163.com functions, such as long-chain non-coding RNA (i.e., RNA that is not translated into protein), miRNA, and small nuclear RNA. circRNA is not as rare a phenomenon as previously thought. Instead, it is abundantly present in eukaryotic cells. In particular, in 2013, a research paper on circRNA was published in Nature [2] , which made circRNA a new hotspot in the research field of RNA following micro RNA and longchain non-coding RNA. Jeck et al. detected up to 25,000 circRNAs in human fibroblasts; Memczak et al. identified 1950 human circRNAs by RNA-Seq data in combination with human leukocyte databases. On August 10, 2017, the Rajewsky team [3] proposed in Science that circRNA at least sometimes plays a role in gene regulation. As a large singlestranded circRNA, it may act as a sponge to absorb miRNAs, and the interaction between circRNA and miRNA was observed through the gene-editing technique CRISPR/Cas9 selectively silencing circRNA.
Sources and Characteristics of circRNA
circRNA is a special non-coding RNA, named for its closed loop. With the development of modern bioinformatics technology, the formation mechanism and biological characteristics of circRNAs have become well known to more and more scholars. According to different genetic sources [4] , circRNAs can be divided into five types: (1) exon-derived circRNAs; (2) exonintron circRNAs, ElciRNAs; (3) intron-derived circRNA; (4) dependent on RBPs-forming circRNA; (5) the formation of circRNA depends on the variable cyclization mode.
The main features of circRNA are as follows: (1) circRNA is widely present in a variety of eukaryotic organisms. Memczak et al. [2] identified 1903 mice circRNA (81 of which are the same as human circRNA) and 724 species of nematode circRNA by RNA-Seq data. Studies have also found that circRNA is also prevalent in archaea cells, and its content is more than 10 times higher than that of linear miRNA. In addition, circRNA was also found in the cytoplasm, serum exosomes, and human body fluids. (2) circRNA has strong stability, and its unique closed-loop structure cannot be recognized by nucleases, and thus is not easily hydrolyzed. At the same time, the half-life of circRNA is longer than that of miRNA and even reached more than 48 h. (3) circRNA has temporal and spatial specificity, and its expression at a different time and different tissues are significantly different. For example, circRims2 is a kind of circRNA in mice. Its content in the brain is about 20 times that of other tissues; (4) it is highly conserved, but some has rapid evolutionary changes; (5) most of them are derived from exons, and a few are formed by direct cyclization of introns; (6) they can act as competitive endogenous RNA, playing the role of miRNA molecular sponge in cells; (7) most of them are non-coding RNAs; (8) most circRNAs can play a regulatory role at the transcriptional or post-regulatory level. A few can only play a role at the transcription level.
Functions of circRNA
Numerous studies have confirmed that circRNA has the molecular sponge effect of miRNA and can regulate gene transcription and gene coding. The role of the molecular sponge is reflected in that as an endogenous RNA, it can indirectly regulate gene expression by inhibiting the function of miRNA through competition. The ability of circRNA to bind to miRNA is the strongest in competitive endogenous RNA and is therefore referred to as the Bsuper sponge^ [5] . circRNA can also directly regulate other RNA levels through base-complementing pairing, binding to RNA-binding proteins to regulate protein function, such as inhibition of gene transcription by binding to transcription factors. Currently, it has been found that lipopolysaccharide can induce macrophage expression of circRNA RasGEF1B (RasGEF domain family member 1B), which is mainly distributed in the cytoplasm. The knockout of circRNA RasGEF1B in macrophages leads to a decrease in lipopolysaccharide-induced expression of intercellular adhesion molecule-1, which is achieved by regulating the stability of intercellular adhesion molecule-1 mRNA [6, 7] . Although circRNA belongs to non-coding RNA, a few circRNAs can encode polypeptides, through which the regulatory functions are performed. On March 16, 2017, the journal Molecular Cell published two important research papers on circRNA online. The corresponding author of one paper was Professor Irene Bozzoni, who introduced the discovery of circRNA circ-znf609 directly translating protein, which is involved in the musculogenesis process [8] . In another article, the corresponding author is Professor Sebastian Kadener, introducing the discovery of a large number of circRNA translation proteins or polypeptides based on ribosome footprinting in fruit fly brains [9, 10] .
However, the most important function of circRNA is molecular sponge action, which plays an important role in many fields, and is currently a hot topic.
At present, ciRS-7 (circRNA sponges of miRNA-7) is the most intensively studied [11] . It is about 1500 nucleotides long and contains 70 binding sites of miRNA-7, and its affinity with miRNA-7 is stronger than that of its target gene CDRlas. Memczak et al. [2] found that overexpression of ciRS-7 in marine fish has the same effect as miRNA-7 knockout, confirming the sponge adsorption of miRNAs by circRNAs.
Studies [12] have also shown that high-glucose-induced human umbilical vein endothelial cells are sequenced in the second generation, and differentially expressed circZNF609 is screened to confirm that circZNF609 sponge adsorbs miR-615-5p; silencing circZNF609 promotes globular sprouting, tubule formation, and retinal vascular endothelial cells proliferation, circRNA can interfere with the proliferation and development of vascular endothelial cells, which in turn affects vascular function.
Despite this, a study by Boeckel et al. [13] analyzed the difference in expression of circRNA in human umbilical vein endothelial cells under normal conditions and hypoxia, and screened out the target circRNA zinc finger protein 292 (cZNF292), which was formed by splicing exon 4 and exon 1A. Hypoxia induction increased the expression level of circZNF292; silencing circZNF292 can affect spheroid germination and lumen formation, inhibit the proliferation of endothelial cells, and further affect the angiogenesis of vascular endothelial cells under hypoxia. However, no binding sites of miRNA were found, indicating that cZNF292 did not play its role by acting as a miRNA sponge.
circRNA, with its rich content, high stability and tissue specificity, has become a research hotspot in recent years. A large number of studies have found that circRNA plays an important role in a variety of diseases, including tumor, heart disease, diabetes, arthritis, and Alzheimer's disease [14] [15] [16] [17] [18] . In 2015, Rybak Wolf [19] [20] [21] found a large number of circRNAs in mammalian nervous system tissues, and with the development of the brain, the expression of circRNA increased. The gene ontology analysis of circRNA in the brain showed that most of the genes involved in circRNA are synapses-related genes; high-resolution fluorescence in situ hybridization experiment confirmed that circRNA exists in neuronal cell bodies and dendrites, suggesting that circRNA may in the pathophysiological process of nervous system diseases play an important role [21, 22] .
A large number of studies have found that immune cells play an important role in cerebrovascular disease, and the immune system-mediated inflammatory response is closely related to the occurrence of cerebral atherosclerosis and intracranial aneurysms [23] [24] [25] . It was found that part of circRNAs can participate in the immune response and miRNA-138 can regulate the differentiation balance of Th1 cells and Th2 cells. circRNA Sry contains 16 miR138 binding sites, and their co-expression can reduce the expression level of miR138 by 4 times, so the circRNA Sry can affect the secretion of cytokine interferon gamma and interleukin-4. Thus, circRNA-mediated inflammatory response plays a crucial role in the pathologic process of cerebrovascular disease. PengYan Xia et al. [26] successfully constructed Cia-cGAS knockout mice by Cas-9 gene knockout strategy. In Cia-cGAS knockout mice, LT-HSC was significantly decreased and type I IFN expression was increased.
Study of circRNA in Cerebrovascular Diseases
Current studies have shown that circRNAs are closely related to cerebrovascular diseases and play a role in the regulation mechanisms of atherosclerosis, vascular endothelial cells, low-density lipoprotein metabolism, smooth muscle cells, inflammatory oxidative stress, and ischemia-reperfusion. We reviewed the research progress of circRNAs in the occurrence and development of cerebrovascular diseases.
circRNA Regulates Atherosclerosis
Ischemic cerebrovascular disease is usually acute onset; it is characterized by high incidence, high mortality, and high disability rate [27] [28] [29] due to the lack of effective treatment methods. Atherosclerosis is an important risk factor for ischemic stroke; it is the key to the prevention and treatment of stroke [30] [31] [32] . The p21 region of the short arm of chromosome 9 (9p21) is an important locus associated with human atherosclerotic disease. The ANRIL (antisense non-coding RNA) gene in the cycle-protein-dependent kinase 4 (INK4) locus is located in the p21 region, and its increased expression is closely related to atherosclerosis. Linear transcripts have been shown to be risk factors for atherosclerosis; circANRIL is an antisense transcript at the INK4A-ARF gene locus. CANRIL can increase the risk of atherosclerotic cerebrovascular disease by regulating the expression of INK4/ARF, suggesting that circRNA may be closely related to the development of atherosclerotic cerebrovascular disease Table 1 [23, 33] .
circRNA Regulates Apoptosis of Vascular Endothelial Cells
Endothelial cells, located in the innermost layer of blood vessels, can produce and secrete bioactive substances, which play an important role in maintaining blood vessel tension and regulating blood pressure and anti-thrombosis. When endothelial cells are stimulated by the outside world, functional changes will occur, leading to a variety of cerebrovascular diseases, such as intracranial aneurysms, atherosclerosis, and cerebral thrombosis [39] [40] [41] .
A recent study showed that circANRIL can be a competitive ribosome assembly factor (Pescadillo homolog 1, PES1) and decreases in vascular smooth muscle cells, and macrophages exonuclease mediated the precursor of ribosomal RNA processing. Furthermore, rRNA processing maturation and ribosome synthesis are affected, resulting in increased nucleoli, reduced volume, and activation, which can affect the apoptosis of vascular endothelial cells and the generation of inflammatory factors, reduce the risk of atherosclerosis, and reduce the incidence rate of cerebrovascular diseases. circRNA is a potential target for drug intervention in atherosclerosis [23] .
In another study, microarray technology was used to compare the expression profiles between endothelial cells cultured with low-density lipoprotein and endothelial cells cultured under normal conditions [35] . It was found that 24 circRNA expressions were significantly altered, with the most significantly upregulated circRNA-104137 and the most significantly downregulated circRNA-100188. By analyzing the binding sites of these two circRNAs, the miRNAs that bind to them were found. Low-density lipoprotein can promote the production of atherosclerosis. Oxidized low-density lipoproteins are likely to alter the expression of circRNA to mediate the development of atherosclerosis.
The CRIM1 gene-derived circ-006839 is differentially expressed at different reperfusion points after stroke. The cysteine-rich motor neuron 1 protein (CRIM1) is a kind of transmembrane protein that binds to a variety of growth factors including transforming growth factor beta and vascular endothelial growth factor, and forms a complex with betacatenin and cadherin, affecting cell junctions and the development of the nervous system; CRIM1 gene defects affect the proliferation of vascular endothelial cells and promote endothelial cell apoptosis. It suggests that CRIM1-related circ-006839 is associated with post-stroke vascular dysfunction. It also affected various pathological and physiological processes after stroke [37] .
circRNA Regulates Apoptosis of Arterial Smooth Muscle Cells
Smooth muscle cells are important components of blood vessels, and their functions of proliferation, apoptosis, migration, and secretion play an important role in the occurrence and development of various cerebrovascular diseases. Studies have found [42, 43] that malignant proliferation of vascular smooth muscle cells can lead to the formation of atherosclerotic plaque, and under certain conditions, it could be converted from a normal contractile state to a synthetic state, producing some elastic fibers, collagen fibers, etc., affecting the occurrence and development of atherosclerosis. Hemodynamic changes stimulate vascular smooth muscle cell phenotype changes, leading to revascularization and mediating the production of intracranial aneurysms.
Current studies on circRNA in vascular smooth muscle cells have found that circRNA hsa-circ-000595 can regulate the apoptosis of vascular smooth muscle cells [34] , while the apoptosis of vascular smooth muscle cells can lead to the thinning of atherosclerotic plaques and promote the rupture of plaques. The effects of circRNA on proliferation, migration, and secretion of vascular smooth muscle cells and the occurrence and development of cerebrovascular diseases need further study.
circRNA Regulates the Progression of Cerebrovascular Disease
Recent studies [44] have found that the expression profile of circRNA in brain tissue changes under cerebral ischemia, and some circRNA may be involved in the pathogenesis of cerebral ischemia, including post-stroke inflammation, oxidative stress, transcription factors, apoptosis-related proteins, and ischemia-reperfusion injury.
circRNA-000741 produced by the AKAP7 gene affected the expression of multiple transcription factors and apoptosisrelated proteins after stroke. A-kinase anchor protein 7 (AKAP7) is mainly expressed in lymphocytes, which is closely related to the integrity of the blood-brain barrier [45] . In the study of the effect of circRNA on post-stroke transcription [36] factors, finding it expresses increased significantly in peripheral blood after stroke. The circ-015350 generated by the NcoA2 gene is associated with various biological processes such as post-stroke apoptosis and oxidative stress. Nuclear receptor coactivator2 (NcoA2) is a co-activator of transcription factors, which can regulate the activity of transcription factors and also inhibit the activity including hypoxia-inducible factor 1 and aromatic hydrocarbon receptor protein, affecting the generation of tubules and thereby affecting the proliferation and development of vascular endothelial cells. The circ-015350 regulates the activity of transcription factors, providing potential drug targets for post-stroke protective treatment [44, 46] .
In the study of the middle cerebral artery occlusion model, Mehta et al. [44] observed the significant changes in the expression of circRNAs in the middle cerebral artery reperfusion of mice by chip detection. In addition, the prediction of the combined miRNAs and their downstream biological processes suggested that circRNAs were involved in the pathophysiological processes after stroke. Hypoxia can lead to the development of the ischemic cerebrovascular disease, and the hypoxic environment can also induce some factors. circRNA can change the expression in response to a hypoxic environment, affecting the expression of hypoxia-inducible factor and vascular endothelial growth factor, and thus affecting the formation of blood vessels and the growth of endothelial cells regulate the development of cardiovascular and cerebrovascular diseases [47] .
In the study of the cerebral ischemia-reperfusion model, Liu et al. [36] established a model of glucose oxygen deprivation/reoxygenation in mouse hippocampal neurons HT22 cells, and screened by circRNA microarray, and found that three expressions of circRNA and 12 expressions were decreased. The circRNA, a target circRNAs capable of adsorbing miRNAs through sponges, affects apoptosis and immune-related processes, suggesting involvement in the pathophysiological process of cerebral ischemia-reperfusion injury. Among them, circRNA-015947 may be involved in the process of cerebral ischemia-reperfusion injury.
Apoptosis-related proteins PARP, which exist in the nucleus, are closely associated with DNA damage repair. Studies have found that [38] upregulation of miRNA-7 can affect cell apoptosis by acting on the downstream target PARP and resist ischemia-reperfusion injury, suggesting that ciRS-7/miRNA-7 is involved in the molecular regulation of vascular injury, all of which provide potential ideas for the targeted treatment of circRNAs for cerebrovascular diseases.
Conclusion
The above studies show that circRNA plays a crucial role in the regulation of vascular endothelial cells, smooth muscle cells, inflammatory oxidative stress, ischemia-reperfusion, and low-density lipoprotein metabolism, which is helpful to reveal the molecular mechanism of circRNA regulating the occurrence and development of cerebrovascular diseases. circRNAs as a kind of non-coding RNA, because of its abundant, high stability and tissue specificity, has become a research hotspot in recent years [9, [48] [49] [50] , but with the differential expression spectrum of circRNA in patients with atherosclerotic ischemic stroke and the pathologic physiology mechanism research only at the early stage, we believe that circRNA is expected to become a potential marker and drug molecular target in the field of cerebrovascular disease because of its unique advantages. It provides new ideas for the occurrence, development, diagnosis, treatment, and rehabilitation of cerebrovascular diseases.
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